An innovative diagnosis in gastrointestinal neuroendocrine neoplasms using Wax-Physisorption-Kinetics-based FTIR Imaging.
Carcinoma, Neuroendocrine
/ pathology
Gastrointestinal Neoplasms
/ diagnostic imaging
Humans
Intestinal Neoplasms
/ pathology
Ki-67 Antigen
/ metabolism
Kinetics
Neuroendocrine Tumors
/ diagnostic imaging
Pancreatic Neoplasms
/ pathology
Polysaccharides
Spectroscopy, Fourier Transform Infrared
Stomach Neoplasms
/ pathology
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 10 2022
13 10 2022
Historique:
received:
23
03
2022
accepted:
11
10
2022
entrez:
13
10
2022
pubmed:
14
10
2022
medline:
18
10
2022
Statut:
epublish
Résumé
Neuroendocrine neoplasm (NEN) is a common gastrointestinal (GI) tract tumor divided into the neuroendocrine tumor (NET) and neuroendocrine carcinoma (NEC) according to mitosis and Ki-67 index. However, the objective discordance between interobserver may cause unsuitable diagnosis and misleading treatment. Nowadays, aberrant glycosylation of glycoconjugates inducing further populations of elongated complex oligosaccharide covalent attached to glycoconjugates anchored in the cell membrane by neo-synthesis of cancer-associated alteration of carbohydrate determinants were observed during cancer development. This study aimed to demonstrate the wax physisorption kinetics coupled with Fourier transform infrared (WPK-FTIR) imaging between NET and NEC in the rectum, colon, and stomach by utilizing two wax reagents (beeswax and paraplast) as glycan adsorbents for physical binding glycans of glycoconjugates based on dipole-induced dipole interaction. Results showed greater physisorption with beeswax than that of paraplast, suggesting highly populated elongated glycans of glycoconjugates adhering onto the tumor surfaces of NETs than that of adjacent benign mucosa in the rectum and colon. Besides, the WPK results of gastric NEN tissue sections showed a higher infrared absorbance ratio of beeswax-remnant to paraplast-remnant remains onto the tissue sections referring to a higher population of elongated glycans in gastric NET as compared with that of gastric NEC. Based on our findings, different anatomical locations could share similar phenomena with minor variance. In conclusion, WPK-FTIR imaging may have the potential to be employed as an alternative diagnostic method in GI NENs in the future.
Identifiants
pubmed: 36229592
doi: 10.1038/s41598-022-22221-0
pii: 10.1038/s41598-022-22221-0
pmc: PMC9561724
doi:
Substances chimiques
Ki-67 Antigen
0
Polysaccharides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17168Informations de copyright
© 2022. The Author(s).
Références
J Clin Oncol. 2008 Jun 20;26(18):3063-72
pubmed: 18565894
PLoS One. 2013 Apr 22;8(4):e62487
pubmed: 23614051
Electrophoresis. 2019 Jan;40(1):140-150
pubmed: 30246896
Anal Bioanal Chem. 2013 Feb;405(6):1995-2007
pubmed: 23318761
Syst Rev. 2017 Oct 10;6(1):196
pubmed: 29017563
Gynecol Oncol. 2004 Apr;93(1):59-68
pubmed: 15047215
Front Oncol. 2014 Feb 07;4:15
pubmed: 24570896
Int J Mol Sci. 2016 Mar 22;17(3):427
pubmed: 27011183
Dis Markers. 2008;25(4-5):207-18
pubmed: 19126965
Int J Mol Sci. 2014 Oct 08;15(10):17963-73
pubmed: 25299694
Cancer Res. 1983 Nov;43(11):5138-44
pubmed: 6616451
BMC Cancer. 2020 Nov 14;20(1):1104
pubmed: 33189127
Cancer Cell. 2017 Jun 12;31(6):733-735
pubmed: 28609653
Biochim Biophys Acta. 2008 Mar;1780(3):525-31
pubmed: 17980710
Cancer Lett. 2009 Feb 18;274(2):208-17
pubmed: 18954939
Cancer Res. 2011 Oct 15;71(20):6295-9
pubmed: 21972148
Oncotarget. 2017 Mar 28;8(13):22123-22134
pubmed: 27902460
Endocrinol Metab Clin North Am. 2011 Mar;40(1):1-18, vii
pubmed: 21349409
J Histochem Cytochem. 2012 Jan;60(1):9-21
pubmed: 22205677
Adv Ther. 2018 Oct;35(10):1497-1509
pubmed: 30218345
PLoS One. 2015 Nov 16;10(11):e0141253
pubmed: 26569621
Cancer. 2014 Sep 15;120(18):2814-23
pubmed: 24771552
Cancer Res. 2008 Jan 15;68(2):388-94
pubmed: 18199532
Front Oncol. 2019 May 14;9:380
pubmed: 31157165
Analyst. 2008 Mar;133(3):372-8
pubmed: 18299752